Clinical Trial Update: A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy [Phase 2]

View source ↗

Summary

Phase 2a proof-of-concept study of GIC-1001 for managing visceral pain during sedation-free, full colonoscopy has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colonic Diseases
• Visceral Pain

Drugs mentioned

• GIC-1001

Snippet

Sponsor: gicare Pharma Inc. | Conditions: Pain, Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-05-08